Why Is SEPTERNA INC (SEPN) Stock Down Today?

Septerna Inc (SEPN) shares fell 10.23% to $46.99, a sharp reversal following a recent run to new highs. The primary driver appears to be a combination of mixed third-quarter financial results and a surge in insider selling activity.

What Happened

The stock opened at $51.90, a slight gap down from the prior close of $52.34, before hitting a session high of $53.34 at 9:30 AM ET. The decline accelerated through the morning, reaching a session low of $45.26 by 10:30 AM ET. While Stifel maintained its Buy rating and raised its price target to $60, and Guggenheim Partners raised its target to $65, the market focused on the company's third-quarter results. Septerna reported an EPS of $(0.57), missing the estimate of $(0.45), and sales of $18.881 million, which fell short of the $20.780 million consensus.

What The Data Shows

The company remains unprofitable with a trailing twelve-month EPS of -1.31 and a net margin of -61.3%, though revenue has grown 336.7% year over year. The stock carries a high beta of 2.20 and a market cap of $2.4 billion. Recent SEC Form 4 filings indicate significant insider activity, with five sells totaling $72.2 million in the last 90 days and no buys. Notable sales include those by Elizabeth Bhatt, President and COO, and Daniel D. Long, SVP of Drug Discovery. The 52-week range spans from $17.98 to $52.53, with the stock printing one fresh 52-week high and 17 fresh 52-week lows on November 11, 2026.

What To Watch

Investors will monitor the company's cash runway, which extends into 2029, and the upcoming readout for SEP-479, a key catalyst for near-term value creation.